Similar Search Results

Beschaffung, Handel und Konsum illegaler Drogen im Strafvollzug - Eine Situationsanalyse -

Filter, Ilona - 2010

Drug consumption is a voluntary decision based on preexisting situational contexts, social events, personal traits and cultural circumstances. Because of this, drug consumption is not pathological but rather normal and ubiquitous. It is only as a result of persecution by the authorities of...

Persistent link: https://www.econbiz.de/10009468267

Illicit Drug Markets and Economic Irregularities

Caulkins, Jonathan P.; Reuter, Peter - 2004

Markets for illicit drugs present an interesting case study for economics, combining non-standard characteristics such as addiction and product illegality. One response has been to argue the generality of economic principles by suggesting that they apply even in the extreme case of markets for...

Persistent link: https://www.econbiz.de/10009441061

Illicit Drug Markets and Economic Irregularities

Caulkins, Jonathan; Reuter, Peter - 2004

Persistent link: https://www.econbiz.de/10009441240

Dr. Peter F. Drucker on business & management, tape 2

Drucker, Peter F. (Peter Ferdinand) - 1994

During Peter Drucker’s talk entitled "From Computer Literacy to Information Literacy" he discusses information systems and how they impact individual enterprises and workers. During his lecture, he talks about: the changing labor force, organization structure, command and control structure,...

Persistent link: https://www.econbiz.de/10009429630

Assessing Quality Improvement Infrastructure in the Formation of Accountable Care Organizations: A Regional Policy Analysis for the Pharmaceutical Industry

Carr-Whealy, Nathan - 2011

Accountable Care Organizations are developing in the United States as a result of the Patient Protection and Affordable Care Act. A study is needed to evaluate an emerging issue of ACOs, quality improvement infrastructure, and the pharmaceutical industry. The convergence of these topics has not...

Persistent link: https://www.econbiz.de/10009434765

Agency Influences on Risk Reduction and Operating Performance: An Empirical Investigation Among Strategic Groups

Veliyath, Rajaram; Ferris, Stephen P. - 1997

The relationships between risk and performance were tested employing within and between analyses at the level of strategic groups in three different industries. As hypothesized, systematic risk did not exhibit a consistent relationship with performance. By contrast, all of the total...

Persistent link: https://www.econbiz.de/10009459032

Making connections: the importance of human relationships in innovative practice

Bruce, Fraser; Baxter, Seaton - 2008

parent company are concerned separately with the development of pharmaceuticals (or drugs) and a wide range of new drug …

Persistent link: https://www.econbiz.de/10009463504

Valuing Water - A Globally Sustainable Approach for the Pharmaceutical Industry

Donnelly, Kristina; Dorau, Therese; Koslow, Melinda; … - 2008

Water resources around the globe are at risk from expanding demand and decreasedavailability. All sectors of society rely on water for operation – agriculture, industry, powergeneration, and domestic users all require a constant, clean supply. As a result of populationgrowth and environmental...

Persistent link: https://www.econbiz.de/10009476746

Novartis and the United Nations Global Compact Initiative

Tavis, Lee A. - 2002

The spirit of the Global Compact found fertile ground and has become an integral part of Novartis corporate strategy since the enterprise was formed by the merger of the two large Swiss pharmaceutical companies, Sandoz and Ciba, in 1996. Following a four-year concentration on economic...

Persistent link: https://www.econbiz.de/10009476845

Consumer construction of the agricultural biotechnology industry's legitimacy: An empirical test of values congruency as institutional and actional legitimacy formation

Mosley, Raul A - 2006

institutional legitimacy) and to market drug-producing crops called Plant Made Pharmaceuticals (an instance of actional legitimacy …. Consumers were more slightly more likely to acknowledge the industry's right to market Plant Made Pharmaceuticals (r = .257 … as a big business entity and to market Plant Made Pharmaceuticals. …

Persistent link: https://www.econbiz.de/10009430368